SHARx, LLC.

07/29/2026

Sophie Cunningham knows how to make a point on the court, and now she is helping turn the national spotlight onto the prescription affordability crisis. As a brand ambassador for SHARx and a member of our Rising Tides Army, the Missouri native is using her platform to call out the high-cost drug dilemma that impacts millions of households and business budgets every day.

"Sophie is more than a competitor and a teammate," SHARx CEO Corey Durbin said. "People trust her because she shows up with conviction. This is not about turning a meme into a marketing stunt but rather accentuating Rising Tides as a cultural movement that points people toward a problem and welcomes more people to SHARx as we solve it together."

Read our latest press release to learn how we are partnering with trusted voices to break through industry jargon, challenge the status quo, and bring sound solutions to high-cost medications:

Sophie Cunningham knows what it means to make a point. The mid-Missouri native, former Tiger standout, and now Indiana Fever guard has had another viral moment after an on-court pointing moment turned into a national meme. But for SHARx, a patient prescription advocacy company, Cunningham’s growin...

07/28/2026

This past weekend, our SHARx team rolled up their sleeves alongside Crisis Aid International and The Tabernacle to help clean and prep homes rehabbed after the May 2025 tornado, getting them ready for families to move back in. Whether we are supporting our members' access to lifesaving medications or stepping up right here in our St. Louis community, our mission is always the same: making a real difference where it counts.

07/24/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 26th Edition is live!

Healthcare costs continue to rise, but employers are no longer standing still.

This edition touches on:
• Why employers are shifting from cost-shifting to smarter, value-based benefit strategies
• New research showing healthcare affordability gaps continue to widen
• Why prescription drug denials have surged in recent years
• Proposed legislation targeting healthcare consolidation and vertical integration
• How drug pricing reforms are reshaping Big Pharma's future
• The employer cost trends expected to define 2026

Employers are demanding greater transparency, stronger accountability, and more sustainable strategies to manage the rising cost of healthcare.

Check out the twenty-sixth edition: 🔗 https://sharxplan.com/on-the-radar-26th-edition/

07/10/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 25th Edition is live!

Healthcare costs aren't slowing down, and employers are being forced to make increasingly difficult decisions.

In this edition, we cover:
• The PBM industry's largest public relations campaign to date
• Why some experts believe insurance complexity is driving costs more than care itself
• How patent cliffs are fueling another wave of pharmaceutical M&A
• Why employers are unbundling pharmacy benefits to manage GLP-1 costs • The growing momentum behind state-level PBM reform efforts
• Why drug spending is on pace to surpass $1 trillion for the first time

The common thread? Transparency, accountability, and affordability are quickly becoming the defining healthcare conversations of 2026.

Check out the twenty-fifth edition: 🔗 https://sharxplan.com/on-the-radar-25th-edition/

07/04/2026

Happy 250th Independence Day from all of us at SHARx! Wishing everyone a wonderful holiday weekend as we celebrate this historic semiquincentennial milestone.

07/01/2026

Meet Kayla Dairaghi -

Kayla really stands out for her eagerness to learn and her willingness to take on any challenge thrown her way. She puts in great effort across all her tasks, asks thoughtful questions, and always brings a consistently positive attitude and great sense of humor that makes her a true asset and a joy to have on the team.

Thank you, Kayla for all you do!

06/30/2026

Are you a compassionate problem-solver ready to make a real impact? We’re hiring an Advocate at SHARx to provide dedicated, personalized support to members navigating access to high-cost medications.

If you have a strong customer service background, thrive in a fast-paced environment, and want to join a mission-driven team that truly values your contributions, we want to hear from you.

Apply today at https://sharxplan.com/advocate-job-description/ and help us deliver exceptional care every single day.

06/26/2026

'𝐎𝐧 𝐭𝐡𝐞 𝐑𝐚𝐝𝐚𝐫' | 24th Edition is live!

Healthcare costs continue to climb, and the pressure points are becoming impossible to ignore.

This edition covers:
• The hidden revenue streams driving PBM profits and reform efforts
• How patent thickets continue to delay lower-cost generic competition
• Why more employers are moving toward transparent, unbundled PBM models
• The growing impact of prescription access barriers and prior authorization delays
• How direct-pay healthcare and cost-plus pharmacy models are challenging the status quo

The common thread? Transparency is no longer a preference. It's becoming a necessity.

Check out the twenty-fourth edition: 🔗 https://sharxplan.com/on-the-radar-24th-edition/

06/18/2026

Lower drug prices on TrumpRx sounds great. But here's what often gets left out of that conversation:

The real gatekeepers aren't the price tags — they're the systems behind the scenes deciding which drugs are covered, which pharmacies you can use, and whether your prescription gets approved at all.

SHARx exists because transparency isn't enough. Read more about what actually needs to change.

Read more: 🔗 https://sharxplan.com/news/sharx-analyzes-trumprx-transparency-on-drug-costs-doesnt-resolve-pricing-and-access-gatekeeping/

The launch of the TrumpRx platform has put prescription drug pricing back in the spotlight, but lower list prices are only half the battle. The true gatekeepers of affordability and access remain the Pharmacy Benefit Managers (PBMs), whose opaque rebate structures and vertical integration create a ....